These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1686757)

  • 1. Physical dependence liability of dynorphin A analogs in rodents.
    Nakazawa T; Kaneko T; Yoshino H; Tachibana S; Goto M; Taki T; Yamatsu K
    Eur J Pharmacol; 1991 Aug; 201(2-3):185-9. PubMed ID: 1686757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal kappa receptor-mediated analgesia of E-2078, a systemically active dynorphin analog, in mice.
    Nakazawa T; Furuya Y; Kaneko T; Yamatsu K
    J Pharmacol Exp Ther; 1991 Jan; 256(1):76-81. PubMed ID: 1671100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [N-methyl-Tyr1,N-methyl-Arg7-D-Leu8]-dynorphin-A-(1-8)ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat.
    Salas SP; Roblero JS; López LF; Tachibana S; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1992 Sep; 262(3):979-86. PubMed ID: 1356155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of [MeTyr1,MeArg7,D-Leu8]-dynorphin A(1-9)-NHEt and [D-Cys2-Cys5,MeArg7,D-Leu8]-dynorphin A(1-9)-NH2.
    Yoshino H; Arakawa Y; Nakazawa T; Kaneko T; Matsunaga M; Araki S; Ikeda M; Tsuchiya Y; Yamatsu K; Tachibana S
    Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2274-6. PubMed ID: 1980641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic effects of E-2078, a stabilized dynorphin A(1-8) analog, in rhesus monkeys.
    Butelman ER; Vivian JA; Yu J; Kreek MJ; Woods JH
    Psychopharmacology (Berl); 1999 Apr; 143(2):190-6. PubMed ID: 10326782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions.
    Katoh A; Nabeshima T; Kameyama T
    J Pharmacol Exp Ther; 1990 May; 253(2):600-7. PubMed ID: 1971017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
    Scheurer U; Wenger F; Caliezi A; Drack E; Varga L; Halter F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1324-30. PubMed ID: 1969475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate and alpha receptor antagonists block the pressor responses of conscious rats given intravenous dynorphin.
    Thornhill JA; Gregor L; Saunders WS
    Peptides; 1989; 10(1):171-7. PubMed ID: 2568623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of monoaminergic involvement in the antinociceptive action of E-2078, morphine and U-50,488E.
    Nakazawa T; Yamanishi Y; Kaneko T
    J Pharmacol Exp Ther; 1991 May; 257(2):748-53. PubMed ID: 1674534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal dynorphins suppress hindlimb electromyographic activity in rats.
    Stevens CW; Weinger MB; Yaksh TL
    Eur J Pharmacol; 1987 Jun; 138(2):299-302. PubMed ID: 2887441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Des-Tyr1]dynorphin A-(2-17) has naloxone-insensitive antinociceptive effect in the writhing assay.
    Hooke LP; He L; Lee NM
    J Pharmacol Exp Ther; 1995 May; 273(2):802-7. PubMed ID: 7752083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression by dynorphin A and [des-Tyr1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice.
    Takemori AE; Loh HH; Lee NM
    J Pharmacol Exp Ther; 1993 Jul; 266(1):121-4. PubMed ID: 8101214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dynorphin A (1-13) and dynorphin A (1-10) amide on stress-induced analgesia.
    Starec M; Rosina J; Málek J; Krsiak M
    Physiol Res; 1996; 45(6):433-8. PubMed ID: 9085373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-Ala2,F5Phe4-dynorphin amide, an opiate with analgesic and toxic properties.
    Kostrzewa RM; Brus R; Coy DH; Criswell H; Coogan PS; Kastin AJ
    Pol J Pharmacol Pharm; 1992; 44(2):109-20. PubMed ID: 1357636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice.
    Takemori AE; Loh HH; Lee NM
    Eur J Pharmacol; 1992 Oct; 221(2-3):223-6. PubMed ID: 1358653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the opioid system in the anxiolytic effect of diazepam in mice.
    Tsuda M; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1996 Jun; 307(1):7-14. PubMed ID: 8831097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic administration of dynorphin A(1-13) markedly inhibits different behavioural responses induced by cocaine in the mouse.
    Ukai M; Kamiya T; Toyoshi T; Kameyama T
    Neuropharmacology; 1992 Sep; 31(9):843-9. PubMed ID: 1359442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
    Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
    Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [D-Pro10]-dynorphin(1-11) is a kappa-selective opioid analgesic in mice.
    Gairin JE; Gout R; Meunier JC; Cros J
    J Pharmacol Exp Ther; 1988 Jun; 245(3):995-1001. PubMed ID: 2898527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynorphin-(1-13) is a potent in vivo suppressor of vasopressin levels in the rat.
    Haaf JA; Maigret C; Andringa-Bakker EA; van Wimersma Greidanus TB
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):96-101. PubMed ID: 2880444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.